Cargando…

Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient–Provider Communication in the START Study

BACKGROUND: mHealth is a promising means of supporting adherence to treatment. The Start TB patients on ART and Retain on Treatment (START) study included real-time adherence support using short-text messaging service (SMS) text messaging and trained village health workers (VHWs). We describe the us...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirsch-Moverman, Yael, Daftary, Amrita, Yuengling, Katharine A., Saito, Suzue, Ntoane, Moeketsi, Frederix, Koen, Maama, Llang B., Howard, Andrea A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147041/
https://www.ncbi.nlm.nih.gov/pubmed/27930610
http://dx.doi.org/10.1097/QAI.0000000000001202
_version_ 1782473601128071168
author Hirsch-Moverman, Yael
Daftary, Amrita
Yuengling, Katharine A.
Saito, Suzue
Ntoane, Moeketsi
Frederix, Koen
Maama, Llang B.
Howard, Andrea A.
author_facet Hirsch-Moverman, Yael
Daftary, Amrita
Yuengling, Katharine A.
Saito, Suzue
Ntoane, Moeketsi
Frederix, Koen
Maama, Llang B.
Howard, Andrea A.
author_sort Hirsch-Moverman, Yael
collection PubMed
description BACKGROUND: mHealth is a promising means of supporting adherence to treatment. The Start TB patients on ART and Retain on Treatment (START) study included real-time adherence support using short-text messaging service (SMS) text messaging and trained village health workers (VHWs). We describe the use and acceptability of mHealth by patients with HIV/tuberculosis and health care providers. METHODS: Patients and treatment supporters received automated, coded medication and appointment reminders at their preferred time and frequency, using their own phones, and $3.70 in monthly airtime. Facility-based VHWs were trained to log patient information and text message preferences into a mobile application and were given a password-protected mobile phone and airtime to communicate with community-based VHWs. The use of mHealth tools was analyzed from process data over the study course. Acceptability was evaluated during monthly follow-up interviews with all participants and during qualitative interviews with a subset of 30 patients and 30 health care providers at intervention sites. Use and acceptability were contextualized by monthly adherence data. FINDINGS: From April 2013 to August 2015, the automated SMS system successfully delivered 39,528 messages to 835 individuals, including 633 patients and 202 treatment supporters. Uptake of the SMS intervention was high, with 92.1% of 713 eligible patients choosing to receive SMS messages. Patient and provider interviews yielded insight into barriers and facilitators to mHealth utilization. The intervention improved the quality of health communication between patients, treatment supporters, and providers. HIV-related stigma and technical challenges were identified as potential barriers. CONCLUSIONS: The mHealth intervention for HIV/tuberculosis treatment support in Lesotho was found to be a low-tech, user-friendly intervention, which was acceptable to patients and health care providers.
format Online
Article
Text
id pubmed-5147041
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher JAIDS Journal of Acquired Immune Deficiency Syndromes
record_format MEDLINE/PubMed
spelling pubmed-51470412016-12-22 Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient–Provider Communication in the START Study Hirsch-Moverman, Yael Daftary, Amrita Yuengling, Katharine A. Saito, Suzue Ntoane, Moeketsi Frederix, Koen Maama, Llang B. Howard, Andrea A. J Acquir Immune Defic Syndr Supplement Article BACKGROUND: mHealth is a promising means of supporting adherence to treatment. The Start TB patients on ART and Retain on Treatment (START) study included real-time adherence support using short-text messaging service (SMS) text messaging and trained village health workers (VHWs). We describe the use and acceptability of mHealth by patients with HIV/tuberculosis and health care providers. METHODS: Patients and treatment supporters received automated, coded medication and appointment reminders at their preferred time and frequency, using their own phones, and $3.70 in monthly airtime. Facility-based VHWs were trained to log patient information and text message preferences into a mobile application and were given a password-protected mobile phone and airtime to communicate with community-based VHWs. The use of mHealth tools was analyzed from process data over the study course. Acceptability was evaluated during monthly follow-up interviews with all participants and during qualitative interviews with a subset of 30 patients and 30 health care providers at intervention sites. Use and acceptability were contextualized by monthly adherence data. FINDINGS: From April 2013 to August 2015, the automated SMS system successfully delivered 39,528 messages to 835 individuals, including 633 patients and 202 treatment supporters. Uptake of the SMS intervention was high, with 92.1% of 713 eligible patients choosing to receive SMS messages. Patient and provider interviews yielded insight into barriers and facilitators to mHealth utilization. The intervention improved the quality of health communication between patients, treatment supporters, and providers. HIV-related stigma and technical challenges were identified as potential barriers. CONCLUSIONS: The mHealth intervention for HIV/tuberculosis treatment support in Lesotho was found to be a low-tech, user-friendly intervention, which was acceptable to patients and health care providers. JAIDS Journal of Acquired Immune Deficiency Syndromes 2017-01-01 2016-12-08 /pmc/articles/PMC5147041/ /pubmed/27930610 http://dx.doi.org/10.1097/QAI.0000000000001202 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Supplement Article
Hirsch-Moverman, Yael
Daftary, Amrita
Yuengling, Katharine A.
Saito, Suzue
Ntoane, Moeketsi
Frederix, Koen
Maama, Llang B.
Howard, Andrea A.
Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient–Provider Communication in the START Study
title Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient–Provider Communication in the START Study
title_full Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient–Provider Communication in the START Study
title_fullStr Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient–Provider Communication in the START Study
title_full_unstemmed Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient–Provider Communication in the START Study
title_short Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient–Provider Communication in the START Study
title_sort using mhealth for hiv/tb treatment support in lesotho: enhancing patient–provider communication in the start study
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147041/
https://www.ncbi.nlm.nih.gov/pubmed/27930610
http://dx.doi.org/10.1097/QAI.0000000000001202
work_keys_str_mv AT hirschmovermanyael usingmhealthforhivtbtreatmentsupportinlesothoenhancingpatientprovidercommunicationinthestartstudy
AT daftaryamrita usingmhealthforhivtbtreatmentsupportinlesothoenhancingpatientprovidercommunicationinthestartstudy
AT yuenglingkatharinea usingmhealthforhivtbtreatmentsupportinlesothoenhancingpatientprovidercommunicationinthestartstudy
AT saitosuzue usingmhealthforhivtbtreatmentsupportinlesothoenhancingpatientprovidercommunicationinthestartstudy
AT ntoanemoeketsi usingmhealthforhivtbtreatmentsupportinlesothoenhancingpatientprovidercommunicationinthestartstudy
AT frederixkoen usingmhealthforhivtbtreatmentsupportinlesothoenhancingpatientprovidercommunicationinthestartstudy
AT maamallangb usingmhealthforhivtbtreatmentsupportinlesothoenhancingpatientprovidercommunicationinthestartstudy
AT howardandreaa usingmhealthforhivtbtreatmentsupportinlesothoenhancingpatientprovidercommunicationinthestartstudy